Cargando…
The application basis of immuno-checkpoint inhibitors combined with chemotherapy in cancer treatment
Immuno-checkpoint inhibitors (ICIs) bring a promising prospect for patients with cancers, which restrains the growth of tumor cells by enhancing anti-tumor activity. Nevertheless, not all patients benefit from the administration of ICIs monotherapy. The partial response or resistance to ICIs is main...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871553/ https://www.ncbi.nlm.nih.gov/pubmed/36703971 http://dx.doi.org/10.3389/fimmu.2022.1088886 |